Schering-Plough and Merck have managed to fool an estimated 75% of U.S. physicians.
Today in an SEC filing, Schering-Plough revealed that total prescriptions for disaster meds Vytorin and Zetia have dropped by more than 20% from January to April 2008.
Total number of prescriptions were 3,205,000 in January and 2,492,000 in April.
Most bloggers and commentators seem to think this is a dramatic drop.
Reality is that Schering-Plough and Merck have so far been able to retain over 75% of their market. Vytorin’s share of the cholesterol market went from 9 percent to 7.2 percent between January and April. And Zetia’s share fell from 6.7 percent to 5.5 percent.
That is the amazing fact--a drug that has not been proven to work, caused multiple congressional inquiries and major news coverage and it is still selling to the tune of billions of dollars!
Welcome to the world snake oil merchants and the people who help grease their machinery: Your friendly neighborhood doc, who continues to write all those scripts.